Viruses of the non-biological sort

We hope that none of the readers of this blog have had their machines compromised by the recent ransomware attack.  This attack was shut down by malware tech and friends, but created a lot of havoc and dangerous situations when physicians were unable to access their patients records, etc. Since these kinds of attacks will likely become more prevalent in the months to come, please take a look at latest prevention security measures which can be found here:  https://www.ncsc.gov.uk/guidance/protecting-your-organisation-ransomware 
Big thanks to malware tech for this link and for taking out the threat.  

protein expression virtual event 10May2017

Sign up and attend this interactive event on Wednesday.

https://www.labroots.com/ms/virtual-event/gibco-expressionworld-advancing-world-protein-expression



Log in anytime May 10, 2017 after 8:00 am regardless of your time zone

Attendees will receive first-hand knowledge of the newest technologies for high-titer recombinant protein production as well as protein expression system design, workflows, purification, and characterization methods. 

Insulin Pioneers

After attending a meeting of biohacker scientists today doing research on methods to make better, more affordable insulin, we are looking back at the development of insulin and the birth of the modern biotech industry. Here are a few short film clips of interviews with Walter Gilbert and David Goeddel and other insulin related materials:

https://www.dnalc.org/view/15259-Cloning-the-human-insulin-gene-Walter-Gilbert.html

https://www.dnalc.org/view/15927-Isolating-DNA-to-make-human-insulin.html

https://www.dnalc.org/view/15088-Gilbert-s-approach-to-synthesizing-insulin-David-Goeddel.html

https://www.dnalc.org/view/16117-Close-but-no-cigar-Walter-Gilbert.html

https://www.dnalc.org/view/16118-Recombinant-DNA-David-Goeddel.html

https://www.dnalc.org/view/15088-Gilbert-s-approach-to-synthesizing-insulin-David-Goeddel.html

https://www.dnalc.org/view/15255-Producing-human-insulin-using-recombinant-DNA-Walter-Gilbert.html

https://www.dnalc.org/view/15257-Trying-to-produce-insulin-using-recombinant-DNA-Walter-Gilbert.html

https://www.dnalc.org/view/15085-Fierce-competition-to-synthesize-insulin-David-Goeddel.html

https://www.dnalc.org/view/15258-Government-restrictions-on-working-with-recombinant-DNA-Walter-Gilbert.html

https://www.dnalc.org/view/15087-Genentech-s-approach-to-making-insulin-David-Goeddel.html

https://www.dnalc.org/view/15086-Synthesizing-DNA-David-Goeddel.html

https://www.dnalc.org/view/15928-How-insulin-is-made-using-bacteria.html

https://www.dnalc.org/view/15929-How-insulin-is-made-using-yeast.html

https://www.dnalc.org/view/15084-First-steps-toward-making-insulin-David-Goeddel.html

Wenesday 24 April 2017 - The Bugs Within

Emeryville, California:

There will be a seminar on  microbial genomics and next generation sequencing "The Bugs Within: Illumina Sequencing Takes You Inside Human Health" The time is of the seminar is 9:30AM - 12:30.  
More information and registration here
(No cost, hosted by Illumina)

CRISPR/CAS9 Delivery Webinar 4-18-17

Allison Mayle, PhD. Gerstner Sloan-Kettering Teaching Fellow, Memorial Sloan Kettering Cancer Center presents this webinar.  
The webinar covers best practices for increasing CRISPR/Cas9 editing efficiency. Viewers will learn discover online tools to aid in CRISPR/Cas9 design and delivery, and tips for optimizing your CRISPR/Cas9 experiments.

Dr. Mayle will review the factors influencing genome editing, including target sequence selection and CRISPR/Cas9 delivery methods. A comparison of plasmid and viral vector delivery will be provided, as well as an introduction to DNA-free CRISPR/Cas9 ribonucleoprotein reagents. Additionally, Dr. Mayle will cover best practices for CRISPR knock-in mutagenesis via homology-directed repair (HDR) and applications available from new Cas9 protein variants.

The webinar is free but registration is required HERE by the hosts GenScript.

Dragon blood inspires synthetic peptide

The peptide DRGN-1 may have a pharmaceutical application to prevent wounds from becoming infected.

http://www.nature.com/articles/s41522-017-0017-2

win a pink spectrophotometer

This contest will end in a couple of days.  A new DS-11 FX+ will be being given away to a lucky winner, enter here